Solventum Corporation

NYSE:SOLV

Sector

🏥 Health Care

Industries

🦷 Dental Care

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 12.57 B

Share Price

USD 72.63

Avg Daily Volume

1,259,011

Change (1 day)

-0.18%

Change (1 year)

36.22%

Change (YTD)

9.95%

Solventum Corporation Price to Book Ratio (P/B) on June 18, 2025: 4.09

Solventum Corporation Price to Book Ratio (P/B) is 4.09 on June 18, 2025, a 61.44% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Solventum Corporation 52-week low Price to Book Ratio (P/B) is 4.52 on June 18, 2025, which is 10.40% above the current Price to Book Ratio (P/B).
Solventum Corporation 52-week low Price to Book Ratio (P/B) is 2.41 on June 18, 2025, which is -41.04% below the current Price to Book Ratio (P/B).
Solventum Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 3.62.

Daily

From:

To:

Zoom:

Key data

Date	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield

NYSE: SOLV

Solventum Corporation

CEO	Mr. Bryan C. Hanson
IPO Date	April 1, 2024
Location	United States
Headquarters	3M Center
Employees	22,000
Sector	🏥 Health Care
Industries Dental Care 🏥 Hospitals & Clinics 🩺 Medical Instruments 💻 Telehealth

Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.